NCT06071624
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06071624
Title Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Huda Salman
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida 33136 RECRUITING Miami Florida 33136 United States Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center RECRUITING Indianapolis Indiana 46202 United States Details
Albert Einstein Health Network NOT_YET_RECRUITING The Bronx New York 10467 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field